Adeno-Associated Virus (AAV) Gene Therapy Market

Adeno-Associated Virus (AAV) Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

252

Base Year:

2023

Nov - 2024

Format:

Report Code:

VMR-3163

Segments Covered

By Types Luxturna, Zolgensma, Others
By Applications Central Nervous System Diseases, Ocular Diseases, Liver-directed Diseases, Other Hereditary Diseases

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD XX Million
Revenue 2032:	USD XX Million
Revenue CAGR (2024 - 2032):	XX
Fastest Growing Region (2024 - 2032)	XX
Largest Region (2023):	XX

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. Global Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. Global Adeno-Associated Virus (AAV) Gene Therapy Market - by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. Global Adeno-Associated Virus (AAV) Gene Therapy Market - by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. Global Adeno-Associated Virus (AAV) Gene Therapy Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
6. Market comparative analysis
North America Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. North America Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. North America Adeno-Associated Virus (AAV) Gene Therapy Market, by Country
  1. U.S.
    1. U.S. Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. U.S. Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  2. Canada
    1. Canada Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Canada Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  3. Mexico
    1. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Mexico Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
Europe Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. Europe Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. Europe Adeno-Associated Virus (AAV) Gene Therapy Market, by Country
  1. Germany
    1. Germany Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Germany Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  2. UK
    1. UK Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. UK Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  3. France
    1. France Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. France Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  4. Spain
    1. Spain Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Spain Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  5. Italy
    1. Italy Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Italy Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  6. BENELUX
    1. BENELUX Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. BENELUX Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  7. Rest of Europe
    1. Rest Of Europe Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Rest Of Europe Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, by Country
  1. China
    1. China Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. China Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  2. Japan
    1. Japan Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Japan Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  3. India
    1. India Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. India Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  4. South Korea
    1. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. South Korea Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  5. South East Asia
    1. South East Asia Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. South East Asia Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Rest of Asia Pacific Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
Latin America Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, by Country
  1. Brazil
    1. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Brazil Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  2. Argentina
    1. Argentina Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Argentina Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  3. Rest of Latin America
    1. Rest of Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Rest of Latin America Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market - Segment Analysis
1. Overview
2. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Types
  1. By Luxturna
  2. By Zolgensma
  3. By Others
4. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Applications
  1. By Central Nervous System Diseases
  2. By Ocular Diseases
  3. By Liver-directed Diseases
  4. By Other Hereditary Diseases
5. Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, by Country
  1. GCC Countries
    1. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. GCC Countries Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  2. South Africa
    1. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. South Africa Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, By Types
      1. By Luxturna
      2. By Zolgensma
      3. By Others
    2. Rest of Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market, By Applications
      1. By Central Nervous System Diseases
      2. By Ocular Diseases
      3. By Liver-directed Diseases
      4. By Other Hereditary Diseases
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Creative Biolabs
2. Affinia Therapeutics
3. Spark Therapeutics
4. AGC Biologics
5. StrideBio
6. SIRION Biotech
7. Neurophth Biotechnology
8. Belief BioMed
9. BiBo Biopharma Engineering Co. Ltd.
10. Beihai Kangcheng
11. PackGene Biotech
12. Sarepta Therapeutics
13. Carbon BioSciences
14. Kelonia Therapeutics
15. Roche
16. Remedium Bio
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

FAQ

Frequently Asked Question

What is the global demand for Adeno-Associated Virus (AAV) Gene Therapy in terms of revenue?

The global Adeno-Associated Virus (AAV) Gene Therapy valued at USD XX Million in 2023 and is expected to reach USD XX Million in 2032 growing at a CAGR of XX.

Which are the prominent players in the market?

The prominent players in the market are Creative Biolabs,Affinia Therapeutics,Spark Therapeutics,AGC Biologics,StrideBio,SIRION Biotech,Neurophth Biotechnology,Belief BioMed,BiBo Biopharma Engineering Co., LTD.,Beihai Kangcheng,PackGene Biotech,Sarepta Therapeutics,Carbon BioSciences,Kelonia Therapeutics,Roche,Remedium Bio.

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of XX between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Adeno-Associated Virus (AAV) Gene Therapy include

Which region accounted for the largest share in the market?

XX was the leading regional segment of the Adeno-Associated Virus (AAV) Gene Therapy in 2023.

Adeno-Associated Virus (AAV) Gene Therapy Market

Adeno-Associated Virus (AAV) Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Adeno-Associated Virus (AAV) Gene Therapy in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Adeno-Associated Virus (AAV) Gene Therapy Market

Adeno-Associated Virus (AAV) Gene Therapy Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Adeno-Associated Virus (AAV) Gene Therapy in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Adeno-Associated Virus (AAV) Gene Therapy Market

Vantage Point Interactive Dashboard